Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Timoma. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Timoma e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Timoma.
Il medico ha ricevuto una formazione in Oncologia Chirurgica presso il Tata Memorial Hospital di Mumbai e ha completato il MRCS al Royal College of Surgeons di Edimburgo. Iniziando la pratica nel 2000, il medico ha fondato il Curie Manavata Cancer Centre nel 2007. Con 19 anni di esperienza, il medico ha eseguito oltre 50.000 interventi chirurgici per il cancro e ha partecipato a più di 200 studi clinici. Il medico è un autore pubblicato con numerose pubblicazioni internazionali e nazionali. Specializzandosi in Oncologia Chirurgica della Mammella e Toracica, il medico è professore per DNB Superspecialty Surgical Oncology e Breast Surgery presso MUHS.<\/p>
La dottoressa è un'oncologa altamente qualificata specializzata nel trattamento di vari tipi di cancro, inclusi tumori solidi, tumori pediatrici e malignità ematologiche. È esperta in trattamenti sia conservativi che chirurgici, come la procedura di Whipple.<\/p>
Ha completato il suo MBBS al Lady Hardinge Medical College e il MD in medicina interna al Maulana Azad Medical College. Ha proseguito con il DM in Oncologia Medica al Tata Memorial Hospital, dove ha anche lavorato come consulente.<\/p>
È affiliata a società oncologiche internazionali e nazionali e ha esperienza in tumori polmonari, mammari, ginecologici e genitourinari, con un particolare interesse per l'immunoterapia e la terapia metronomica.<\/p>
Il medico è uno specialista esperto in medicina nucleare presso l'HCG Manavata Cancer Centre con 12 anni nel campo. Il medico si specializza in vari esami nucleari, esami PET-CT e servizi di cardiologia nucleare, dimostrando competenza nelle terapie con radioiodio e Lu-177 RN. Nel corso della sua carriera, il medico ha gestito oltre 30.000 esami PET e trattato oltre 1.000 pazienti con cancro alla tiroide. Inoltre, il medico ha contribuito al campo attraverso articoli pubblicati in varie riviste mediche.<\/p>
Thymoma treatment in India follows international protocols focused on the Masaoka-Koga staging system. Primary care involves surgical resection, radiotherapy, and platinum-based chemotherapy. Specialists at NABH-accredited centers use a tumor board approach to tailor therapies based on tumor invasiveness and patient health.
Bookimed Expert Insight: High-volume centers like Medanta Hospital and HCG Manavata Cancer Centre provide specialized thoracic expertise. For example, Dr. Raj Nagarkar has performed over 50,000 oncology procedures. This massive surgical volume is vital for thymoma, as achieving clear margins (R0 resection) is the most critical factor for long-term survival.
Patient Consensus: Patients emphasize finding high-volume thoracic centers rather than general hospitals. They note it is important to confirm if a tumor is fully resectable during initial consultations.
Thymoma surgery risks in India include phrenic nerve injury, myasthenic crisis, and major vessel hemorrhage. The thymus sits near the heart and lungs, requiring precise dissection. Indian centers utilize robotic systems like Da Vinci and PET-CT imaging to manage these complex thoracic procedures and improve safety.
Bookimed Expert Insight: A major quality signal in Indian oncology is the volume of specialized thoracic cases. For example, Dr. Raj Nagarkar at HCG Manavata Cancer Centre has performed over 50,000 surgeries. This high-volume experience is crucial because thymus tumors often adhere to major blood vessels like the superior vena cava. High-volume surgeons are better prepared to manage sudden intraoperative bleeding without complications.
Patient Consensus: Patients emphasize that complete tumor removal is more important than the specific surgical label. Those with myasthenia gravis often note that managing breathing weakness and anesthesia is a bigger concern than the surgery itself.
Biopsy is often unnecessary if imaging shows a localized, removable thymoma. Surgeons at major Indian oncology centers typically proceed directly to surgery. This avoids the risk of tumor seeding and provides a definitive diagnosis. Upfront surgery remains the standard for approximately 80% of suspected cases.
Bookimed Expert Insight: Indian tertiary centers like Medanta or Fortis Gurgaon frequently use cross-function tumor boards for these decisions. Data shows that high-volume surgeons, such as Dr. Raj Nagarkar with over 50,000 surgeries, prioritize preoperative imaging like PET-CT over biopsy. This approach is particularly effective when clinics utilize advanced tools like the Da Vinci robotic system for precise, minimally invasive resection.
Patient Consensus: Patients note it is common for specialists to recommend skipping the biopsy if the mass looks operable. They emphasize that while biopsy is avoided to prevent spreading cells, thorough pre-op testing like pulmonary scans remains essential.
India top hospitals for thymoma management include Tata Memorial Hospital, Medanta The Medicity, and HCG Manavata Cancer Centre. These centers offer specialized thoracic surgical oncology. They utilize multidisciplinary tumor boards. Advanced techniques like robotic thymectomy and video-assisted thoracic surgery (VATS) are standard in these institutions.
Bookimed Expert Insight: Data highlights a regional expertise hub in Nashik. HCG Manavata serves 75,000 patients annually with 40+ oncologists. Specialists here like Dr. Raj Nagarkar and Dr. Shruti Kate bring direct experience from Tata Memorial Hospital. This allows patients to access premier-level oncology protocols in a facility with high capacity and modern standards.
Patient Consensus: Patients emphasize finding a surgeon specifically experienced in rare thoracic tumors rather than general oncology. They note that high-volume tertiary centers provide better coordination for multidisciplinary tumor board reviews.
Long-term survival after thymoma treatment in India is high. Reported 5-year survival rates range from 76% to 90% across all stages. Early-stage cases caught before spreading show a 95% survival rate. Advanced multimodal therapy including surgery and radiation supports favorable outcomes for invasive tumors.
Bookimed Expert Insight: Patients should prioritize centers using multidisciplinary tumor boards, such as Medanta Hospital Gurgaon. Our data shows these committees are vital for thymoma. They coordinate thoracic surgeons like Dr. Raj Nagarkar with nuclear medicine specialists for precise PET-CT staging. This collaborative approach ensures that complex tumors involving surrounding tissues receive the most aggressive and accurate resection possible.
Patient Consensus: Patients note that the emotional stress of long-term CT surveillance is often harder than the surgery. Many emphasize that finding an experienced thoracic surgeon who can achieve full resection is their top priority for peace of mind.
Indian hospitals offer advanced minimally invasive and robotic surgery for thymoma. Surgeons utilize the Da Vinci Surgical System and Video-Assisted Thoracic Surgery (VATS). These techniques are suitable for early-stage tumors. Facilities like Fortis Gurgaon and Dr. Rela Institute specialize in these robotic oncology procedures.
Bookimed Expert Insight: While many search for robotic options, surgery volume is the strongest quality signal. Centers like Manipal Hospitals serve 2,000,000 patients annually. High-volume hospitals often have lower conversion rates from robotic to open surgery. Choosing a facility with a dedicated thoracic oncology department ensures the team can handle complex vascular involvement.
Patient Consensus: Patients emphasize finding a surgeon who prioritizes complete tumor removal over small incisions. They note that choosing a center capable of immediate open conversion is vital for safety if the tumor is near major vessels.
International patients typically stay in India for 3 to 5 weeks for thymoma treatment. This timeframe covers the pre-operative workup and surgical recovery. Patients undergoing minimally invasive thymectomy often spend 3 to 7 days in the hospital. Follow-up monitoring usually requires another 14 to 21 days before travel.
Bookimed Expert Insight: India offers advanced thoracic care through superspecialty networks like Manipal Hospitals and Fortis Gurgaon. Data shows these facilities manage massive patient volumes, with Manipal serving 2,000,000 people annually. Patients should note that leading surgeons like Dr. Raj Nagarkar have performed over 50,000 cancer surgeries. This high surgical volume often leads to faster recovery times and shorter hospital stays for thymectomy patients.
Patient Consensus: Patients emphasize the need for a 2-week buffer because final pathology results can change the treatment plan. It is also common to stay nearby until all surgical drains are removed to ensure safety before long-haul flights.